Safety of a New Synbiotic Starter Formula

Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric gastroenterology, hepatology & nutrition hepatology & nutrition, 2017, Vol.20 (3), p.167-177
Hauptverfasser: Vandenplas, Yvan, Analitis, Antonis, Tziouvara, Chara, Kountzoglou, Athina, Drakou, Anastasia, Tsouvalas, Manos, Mavroudi, Antigoni, Xinias, Ioannis
Format: Artikel
Sprache:kor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 177
container_issue 3
container_start_page 167
container_title Pediatric gastroenterology, hepatology & nutrition
container_volume 20
creator Vandenplas, Yvan
Analitis, Antonis
Tziouvara, Chara
Kountzoglou, Athina
Drakou, Anastasia
Tsouvalas, Manos
Mavroudi, Antigoni
Xinias, Ioannis
description Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.
format Article
fullrecord <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201730048508409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201730048508409</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2017300485084093</originalsourceid><addsrcrecordid>eNpjYuA0MjI20bWwMDFggbHNTMw4GHiLizOTDIwtDMzNjEwMOBk0gxPTUksqFfLTFBIV_FLLFYIr85Iy80sykxWCSxKLSlKLFNzyi3JLcxJ5GFjTEnOKU3mhNDeDqptriLOHbnZmcUlmfF5KcU68l6O3v5GBobmxgYGJhakB0HZLY2LVAQBR5TAZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety of a New Synbiotic Starter Formula</title><source>KoreaMed Synapse</source><source>PubMed Central Open Access</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</creator><creatorcontrib>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</creatorcontrib><description>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</description><identifier>ISSN: 2234-8646</identifier><identifier>EISSN: 2234-8840</identifier><language>kor</language><ispartof>Pediatric gastroenterology, hepatology &amp; nutrition, 2017, Vol.20 (3), p.167-177</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024</link.rule.ids></links><search><creatorcontrib>Vandenplas, Yvan</creatorcontrib><creatorcontrib>Analitis, Antonis</creatorcontrib><creatorcontrib>Tziouvara, Chara</creatorcontrib><creatorcontrib>Kountzoglou, Athina</creatorcontrib><creatorcontrib>Drakou, Anastasia</creatorcontrib><creatorcontrib>Tsouvalas, Manos</creatorcontrib><creatorcontrib>Mavroudi, Antigoni</creatorcontrib><creatorcontrib>Xinias, Ioannis</creatorcontrib><title>Safety of a New Synbiotic Starter Formula</title><title>Pediatric gastroenterology, hepatology &amp; nutrition</title><addtitle>Pediatric gastroenterology, hepatology &amp; nutrition</addtitle><description>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</description><issn>2234-8646</issn><issn>2234-8840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNpjYuA0MjI20bWwMDFggbHNTMw4GHiLizOTDIwtDMzNjEwMOBk0gxPTUksqFfLTFBIV_FLLFYIr85Iy80sykxWCSxKLSlKLFNzyi3JLcxJ5GFjTEnOKU3mhNDeDqptriLOHbnZmcUlmfF5KcU68l6O3v5GBobmxgYGJhakB0HZLY2LVAQBR5TAZ</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Vandenplas, Yvan</creator><creator>Analitis, Antonis</creator><creator>Tziouvara, Chara</creator><creator>Kountzoglou, Athina</creator><creator>Drakou, Anastasia</creator><creator>Tsouvalas, Manos</creator><creator>Mavroudi, Antigoni</creator><creator>Xinias, Ioannis</creator><scope>JDI</scope></search><sort><creationdate>2017</creationdate><title>Safety of a New Synbiotic Starter Formula</title><author>Vandenplas, Yvan ; Analitis, Antonis ; Tziouvara, Chara ; Kountzoglou, Athina ; Drakou, Anastasia ; Tsouvalas, Manos ; Mavroudi, Antigoni ; Xinias, Ioannis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2017300485084093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vandenplas, Yvan</creatorcontrib><creatorcontrib>Analitis, Antonis</creatorcontrib><creatorcontrib>Tziouvara, Chara</creatorcontrib><creatorcontrib>Kountzoglou, Athina</creatorcontrib><creatorcontrib>Drakou, Anastasia</creatorcontrib><creatorcontrib>Tsouvalas, Manos</creatorcontrib><creatorcontrib>Mavroudi, Antigoni</creatorcontrib><creatorcontrib>Xinias, Ioannis</creatorcontrib><collection>KoreaScience</collection><jtitle>Pediatric gastroenterology, hepatology &amp; nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vandenplas, Yvan</au><au>Analitis, Antonis</au><au>Tziouvara, Chara</au><au>Kountzoglou, Athina</au><au>Drakou, Anastasia</au><au>Tsouvalas, Manos</au><au>Mavroudi, Antigoni</au><au>Xinias, Ioannis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of a New Synbiotic Starter Formula</atitle><jtitle>Pediatric gastroenterology, hepatology &amp; nutrition</jtitle><addtitle>Pediatric gastroenterology, hepatology &amp; nutrition</addtitle><date>2017</date><risdate>2017</risdate><volume>20</volume><issue>3</issue><spage>167</spage><epage>177</epage><pages>167-177</pages><issn>2234-8646</issn><eissn>2234-8840</eissn><abstract>Purpose: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. Methods: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. Results: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). Conclusion: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-8646
ispartof Pediatric gastroenterology, hepatology & nutrition, 2017, Vol.20 (3), p.167-177
issn 2234-8646
2234-8840
language kor
recordid cdi_kisti_ndsl_JAKO201730048508409
source KoreaMed Synapse; PubMed Central Open Access; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
title Safety of a New Synbiotic Starter Formula
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A19%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20a%20New%20Synbiotic%20Starter%20Formula&rft.jtitle=Pediatric%20gastroenterology,%20hepatology%20&%20nutrition&rft.au=Vandenplas,%20Yvan&rft.date=2017&rft.volume=20&rft.issue=3&rft.spage=167&rft.epage=177&rft.pages=167-177&rft.issn=2234-8646&rft.eissn=2234-8840&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201730048508409%3C/kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true